- Home
- JFIN vs RVNC Comparison
JFIN vs RVNC Comparison
Compare JFIN & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JFIN
- RVNC
- Stock Information
- Founded
- JFIN 2011
- RVNC 1999
- Country
- JFIN China
- RVNC United States
- Employees
- JFIN N/A
- RVNC N/A
- Industry
- JFIN Finance: Consumer Services
- RVNC Biotechnology: Pharmaceutical Preparations
- Sector
- JFIN Finance
- RVNC Health Care
- Exchange
- JFIN Nasdaq
- RVNC Nasdaq
- Market Cap
- JFIN 381.8M
- RVNC 320.5M
- IPO Year
- JFIN 2019
- RVNC 2014
- Fundamental
- Price
- JFIN $7.30
- RVNC $3.68
- Analyst Decision
- JFIN
- RVNC Hold
- Analyst Count
- JFIN 0
- RVNC 9
- Target Price
- JFIN N/A
- RVNC $7.78
- AVG Volume (30 Days)
- JFIN 160.3K
- RVNC 2.9M
- Earning Date
- JFIN 11-20-2024
- RVNC 02-26-2025
- Dividend Yield
- JFIN 12.33%
- RVNC N/A
- EPS Growth
- JFIN N/A
- RVNC N/A
- EPS
- JFIN 3.08
- RVNC N/A
- Revenue
- JFIN $854,955,021.00
- RVNC $256,945,000.00
- Revenue This Year
- JFIN N/A
- RVNC $11.28
- Revenue Next Year
- JFIN N/A
- RVNC $27.21
- P/E Ratio
- JFIN $2.37
- RVNC N/A
- Revenue Growth
- JFIN 21.87
- RVNC 25.82
- 52 Week Low
- JFIN $4.00
- RVNC $2.30
- 52 Week High
- JFIN $8.58
- RVNC $7.56
- Technical
- Relative Strength Index (RSI)
- JFIN 64.04
- RVNC 61.76
- Support Level
- JFIN $7.03
- RVNC $3.25
- Resistance Level
- JFIN $7.49
- RVNC $3.38
- Average True Range (ATR)
- JFIN 0.35
- RVNC 0.08
- MACD
- JFIN 0.08
- RVNC 0.08
- Stochastic Oscillator
- JFIN 86.99
- RVNC 97.01
About JFIN Jiayin Group Inc.
Jiayin Group Inc is China's technology service group. It is an enterprise engaged in technological innovation services. It is committed to using big data, cloud computing, artificial intelligence and other technologies to connect consumers and financial institutions in consumption scenarios so that every user can enjoy efficient and convenient technology services. The company has engraved technological innovation into the company's development genes since its establishment, adheres to the dual drive of digital + technology, and focuses on building a cloud service platform and intelligent risk control system with big data drive as the core concept.
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.